Published in Gene Therapy Weekly, August 4th, 2005
The KAI Scientific Advisory Board includes the following:
Daria Mochly-Rosen, PhD, KAI founder and chair of the SAB, George D. Smith Professor of Translational Medicine, professor and chair, Department of Molecular Pharmacology, Stanford University. Mochly-Rosen co-founded KAI Pharmaceuticals in 2002.
Robert Bell, PhD, a venture partner...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.